U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445438) titled 'Feasibility of a Multi-omics Platform for Hematological Malignancies' on Feb. 13.
Brief Summary: This is a biological study based on a collaborative effort involving several Italian haematology centres (including the coordinating centre). The study will be conducted retrospectively and prospectively using bone marrow (BM) or peripheral blood (PB) samples, lymph node or tissue biopsies with metastatic involvement, and other biological fluids, such as cerebrospinal fluid and pathological pleural effusion.
Study Start Date: March 31, 2025
Study Type: INTERVENTIONAL
Condition:
Myeloma Multiple
Chronic Leukemia
Acute Leukemia
Myelopr...